Showing results (81-90 of 212) with videos related to
Sort By:
Pageof 22
Haematologica|February 24, 2018
Clinical relevance of <i>IDH1/2</i> mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA groupYann Ferret, Nicolas Boissel, Nathalie Helevaut, et al.Blood Advances|October 29, 2021
Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experienceAva Diarra, Nicolas Duployez, Elise Fournier, et al.Oncotarget|December 30, 2017
Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromesMathieu Meunier, Sarah Ancelet, Christine Lefebvre, et al.Blood Cancer Journal|June 13, 2024
Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA studyPierre Hirsch, Jérôme Lambert, Maxime Bucci, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2015
Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune EvasionZena Khaznadar, Nicolas Boissel, Sophie Agaugué, et al.Haematologica|September 5, 2007
Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutationFranck E Nicolini, Sandrine Hayette, Selim Corm, et al.BMC Bioinformatics|October 28, 2022
Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3rAugustin Boudry, Sasha Darmon, Nicolas Duployez, et al.Blood|January 23, 2014
SET-NUP214 is a recurrent γδ lineage-specific fusion transcript associated with corticosteroid/chemotherapy resistance in adult T-ALLRaouf Ben Abdelali, Anne Roggy, Thibaut Leguay, et al.The Lancet. Haematology|April 12, 2016
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 studyCéline Berthon, Emmanuel Raffoux, Xavier Thomas, et al.Blood|October 6, 2016
LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosisAdam Ceroi, David Masson, Anne Roggy, et al.Pageof 22